Skip to main content

Table 3 Status of menstrual cycle and apparent symptoms among the study population

From: Comparative analysis of clinical symptoms and biochemical alterations in women with polycystic ovary syndrome: assessing the impact of type 1 diabetes versus non-diabetic controls

Variable

Non-diabetic controls (No. = 50)

Diabetic patients (No. = 50)

Test

P-value

Age at menarche (years)

 Mean ± SD

13.2 ± 1.2

13.9 ± 1.6

t

2.368

0.020

 Range (min–max)

11–16

11–18

   

Oligomenorrhea, No. (%)

 Yes

9 (18.0)

17 (34.0)

χ2

3.326

0.068

 No

41 (82.0)

33 (66.0)

   

Acanthosis nigricans, No. (%)

 Yes

0 (0.0)

6 (12.0)

χ2

4.433

0.035*

 No

50 (100)

44 (88.0)

   

Seborrhea, No. (%)

 Yes

2 (4.0)

10 (20.0)

χ2

4.640

0.031*

 No

48 (96.0)

40 (80.0)

   

Hirsutism, No. (%)

 Yes

3 (6.0)

9 (18.0)

χ2

2.367

0.124*

 No

47 (94.0)

41 (82.0)

   
  1. No. number, SD standard deviation; *P-value of χ2(corrected) test, P < 0.05: significant, P > 0.05: not significant